JP2019163253A5 - - Google Patents

Download PDF

Info

Publication number
JP2019163253A5
JP2019163253A5 JP2019052389A JP2019052389A JP2019163253A5 JP 2019163253 A5 JP2019163253 A5 JP 2019163253A5 JP 2019052389 A JP2019052389 A JP 2019052389A JP 2019052389 A JP2019052389 A JP 2019052389A JP 2019163253 A5 JP2019163253 A5 JP 2019163253A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
polypeptide
seq
subsequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019052389A
Other languages
English (en)
Japanese (ja)
Other versions
JP7510142B2 (ja
JP2019163253A (ja
Filing date
Publication date
Priority claimed from JP2016503549A external-priority patent/JP2016514713A/ja
Application filed filed Critical
Publication of JP2019163253A publication Critical patent/JP2019163253A/ja
Publication of JP2019163253A5 publication Critical patent/JP2019163253A5/ja
Priority to JP2021148819A priority Critical patent/JP7506930B2/ja
Application granted granted Critical
Publication of JP7510142B2 publication Critical patent/JP7510142B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019052389A 2013-03-18 2019-03-20 クラミジア種(Chlamydia sp.)に対するワクチン Active JP7510142B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021148819A JP7506930B2 (ja) 2013-03-18 2021-09-13 クラミジア種(Chlamydia sp.)に対するワクチン

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA201300155 2013-03-18
DKPA201300155 2013-03-18
DKPA201300684 2013-12-11
DKPA201300684 2013-12-11
JP2016503549A JP2016514713A (ja) 2013-03-18 2014-03-17 クラミジア種(Chlamydiasp.)に対するワクチン

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016503549A Division JP2016514713A (ja) 2013-03-18 2014-03-17 クラミジア種(Chlamydiasp.)に対するワクチン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021148819A Division JP7506930B2 (ja) 2013-03-18 2021-09-13 クラミジア種(Chlamydia sp.)に対するワクチン

Publications (3)

Publication Number Publication Date
JP2019163253A JP2019163253A (ja) 2019-09-26
JP2019163253A5 true JP2019163253A5 (enExample) 2020-01-16
JP7510142B2 JP7510142B2 (ja) 2024-07-03

Family

ID=50639248

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016503549A Pending JP2016514713A (ja) 2013-03-18 2014-03-17 クラミジア種(Chlamydiasp.)に対するワクチン
JP2019052389A Active JP7510142B2 (ja) 2013-03-18 2019-03-20 クラミジア種(Chlamydia sp.)に対するワクチン
JP2021148819A Active JP7506930B2 (ja) 2013-03-18 2021-09-13 クラミジア種(Chlamydia sp.)に対するワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016503549A Pending JP2016514713A (ja) 2013-03-18 2014-03-17 クラミジア種(Chlamydiasp.)に対するワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021148819A Active JP7506930B2 (ja) 2013-03-18 2021-09-13 クラミジア種(Chlamydia sp.)に対するワクチン

Country Status (20)

Country Link
US (4) US20140275478A1 (enExample)
EP (1) EP2976355B1 (enExample)
JP (3) JP2016514713A (enExample)
CN (2) CN113185587A (enExample)
AU (1) AU2014234765B2 (enExample)
BR (1) BR112015023886B1 (enExample)
CA (1) CA2907199C (enExample)
CY (1) CY1122905T1 (enExample)
DK (1) DK2976355T3 (enExample)
ES (1) ES2781579T3 (enExample)
HR (1) HRP20200511T1 (enExample)
HU (1) HUE048573T2 (enExample)
LT (1) LT2976355T (enExample)
PL (1) PL2976355T3 (enExample)
PT (1) PT2976355T (enExample)
RS (1) RS60135B1 (enExample)
RU (1) RU2723046C2 (enExample)
SI (1) SI2976355T1 (enExample)
SM (1) SMT202000160T1 (enExample)
WO (1) WO2014146663A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016130667A1 (en) 2015-02-10 2016-08-18 Ohio State Innovation Foundation Chlamydia-activated b cell platforms and methods thereof
CN104800841B (zh) * 2015-03-02 2019-04-02 中国农业科学院兰州兽医研究所 牦牛流产衣原体灭活疫苗及其制备方法
KR20170134978A (ko) * 2015-03-24 2017-12-07 유니버시테이트 젠트 클라미디아 수이스의 검출을 위한 방법 및 펩타이드
WO2017075653A1 (en) * 2015-11-04 2017-05-11 University Of The Sunshine Coast Chlamydia antigens and uses thereof
CA3004924A1 (en) 2015-11-10 2017-05-18 Ohio State Innovation Foundation Methods and compositions related to accelerated humoral affinity
NL2019320B1 (en) * 2017-03-02 2018-09-21 Biosparq B V Diagnostic method and system for diagnosis
WO2018175875A1 (en) * 2017-03-23 2018-09-27 Ohio State Innovation Foundation Recombinant chlamydia-activated b cell platforms and methods of use thereof
RU2721123C1 (ru) * 2019-09-26 2020-05-18 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Штамм рекомбинантной псевдоаденовирусной частицы, экспрессирующий химерный ген MBL-CT666 Chlamydia trachomatis, способ его получения, иммуногенная композиция для защиты от урогенитального хламидиоза человека
US20240131138A1 (en) * 2020-12-23 2024-04-25 Institut National De La Santé Et De La Recherche Médicale (Inserm) Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells
CN116854812B (zh) * 2022-03-23 2024-09-24 东莞市朋志生物科技有限公司 抗沙眼衣原体的抗体、检测沙眼衣原体的试剂和试剂盒
CN115975049A (zh) * 2022-11-12 2023-04-18 北京成大天和生物科技有限公司 一种沙眼衣原体重组蛋白及其制备方法和应用
AR132053A1 (es) * 2023-03-02 2025-05-21 Sanofi Pasteur Composiciones para su uso en el tratamiento de clamidia
AU2024381228A1 (en) 2023-11-13 2026-05-28 Ziphius Nv MODIFIED ALPHAVIRAL nsP3

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
US5869608A (en) * 1989-03-17 1999-02-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
CA2141427C (en) * 1992-07-31 2008-07-22 Mohammed Anjam Khan Expression of recombinant fusion proteins in attenuated bacteria
AU669000B2 (en) 1992-09-18 1996-05-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Synthetic peptide vaccine for chlamydia trachomatis
GB9516293D0 (en) * 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
JP2002512622A (ja) * 1997-05-06 2002-04-23 バンダービルト ユニバーシティー クラミジアにより引き起こされる感染の診断および管理のための抗クラミジア剤の組成物
EP1345617A2 (en) * 2000-12-22 2003-09-24 Synovis Limited Methods of modulating toll-related receptor (trr) signaling
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
WO2005002619A2 (en) * 2003-06-26 2005-01-13 Chiron Corporation Immunogenic compositions for chlamydia trachomatis
JP5024830B2 (ja) * 2004-10-25 2012-09-12 ステーテンズ セーラム インスティテュート クラミジア・トラコマチス(Chlamydiatrachomatis)抗原のワクチンおよび診断への使用
US7964200B2 (en) * 2005-05-18 2011-06-21 Children's Hospital & Research Center At Oakland Methods and compositions for immunizing against Chlamydia infection
TW201012929A (en) * 2008-09-29 2010-04-01 Univ Nat Pingtung Sci & Tech A hybridoma cell line producing monoclonal antibodies against chalmydophila aborts
EP2907523B1 (en) * 2009-01-29 2018-03-28 British Columbia Cancer Agency Branch Compositions comprising chlamydia antigens
US8735543B2 (en) * 2010-05-28 2014-05-27 Spixia Biotechnology Ab Chimeric MOMP antigen
WO2012172042A1 (en) * 2011-06-17 2012-12-20 Universiteit Gent Vaccines for chlamydia

Similar Documents

Publication Publication Date Title
JP2016514713A5 (enExample)
RU2015141214A (ru) Вакцины против Chlamydia sp.
CA2187083C (fr) Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation
JP2010522540A5 (enExample)
JP2023156353A5 (enExample)
JP2018171063A5 (enExample)
JP2021519599A5 (enExample)
JP2021519597A5 (enExample)
JP2016196472A5 (enExample)
Abdel-Aal et al. Structure–activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates
HRP20161353T1 (hr) Rekombinantni rsv antigeni
JP2011528222A5 (enExample)
JP2008536483A5 (enExample)
JP2009544333A5 (enExample)
JPWO2019107530A5 (enExample)
JP2009520758A5 (enExample)
JP2015505831A5 (enExample)
JP2006506942A5 (enExample)
JP2021502807A5 (enExample)
JP2013520487A5 (enExample)
JP2025521082A5 (enExample)
JP2023537070A5 (enExample)
JP2008522954A5 (enExample)
JP2021522239A5 (enExample)
WO2024047090A3 (en) Modified virus-like particles of cmv